GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA completes inspection at Granules India's Hyderabad facility15-02-2020
15-02-2020
Granules India gets tentative nod from USFDA for expectorant tablets
"US Food Drug Administration (USFDA) has tentatively approved its Abbreviated New Drug Application for Guaifenesin extended-release tablets, 600 mg and 1200 mg (OTC)," the company said in a filing to the BSE.13-02-2020
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Conference call with the Investors.13-02-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release: Granules India Limited announces tentative approval of Guaifenesin ER Tablets, 600 mg and 1200 mg (OTC), generic equivalent of Mucinex(r) ER Tablets, 600 mg and 1200 mg, of RB Health (US) LLC.13-02-2020
Granules gets nod from USFDA for generic Colchicine capsules
Drug firm Granules India has received tentative approval from the US health regulator for its generic Colchicine capsules indicated for prevention o11-02-2020
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release: Granules India Limited announces tentative approval of Colchicine Capsules, 0.6 mg.11-02-2020
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement confirming dispatch of Postal Ballot Notice.10-02-2020
GRANULES INDIA LTD.-$ - 532482 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice07-02-2020
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Conference call with the Investors.07-02-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release:Granules India Limited receives approval from US Food & Drug Administration (US FDA) of Colchicine Tablets used for the treatment of Familial Mediterranean Fever (FMF).06-02-2020